These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36004490)

  • 1. The homeostasis and therapeutic applications of innate and adaptive immune cells in periodontitis.
    Junxian L; Mehrabanian M; Mivehchi H; Banakar M; Etajuri EA
    Oral Dis; 2023 Oct; 29(7):2552-2564. PubMed ID: 36004490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
    Kaur S; White S; Bartold M
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy with regulatory T and B cells in periodontitis.
    Zou J; Zeng Z; Xie W; Zeng Z
    Int Immunopharmacol; 2022 Aug; 109():108797. PubMed ID: 35487085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review.
    Reddy MS; Geurs NC; Gunsolley JC
    Ann Periodontol; 2003 Dec; 8(1):12-37. PubMed ID: 14971246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local anti-infective therapy: pharmacological agents. A systematic review.
    Hanes PJ; Purvis JP
    Ann Periodontol; 2003 Dec; 8(1):79-98. PubMed ID: 14971250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast Cell Cytokines in Acute and Chronic Gingival Tissue Inflammation: Role of IL-33 and IL-37.
    Trimarchi M; Lauritano D; Ronconi G; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Calvisi V; Conti P
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt signaling: An attractive target for periodontitis treatment.
    Bao J; Yang Y; Xia M; Sun W; Chen L
    Biomed Pharmacother; 2021 Jan; 133():110935. PubMed ID: 33227711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effect of ATB-352, a H2S -releasing ketoprofen derivative, on lipopolysaccharide-induced periodontitis in rats.
    Gugliandolo E; Fusco R; D'Amico R; Militi A; Oteri G; Wallace JL; Di Paola R; Cuzzocrea S
    Pharmacol Res; 2018 Jun; 132():220-231. PubMed ID: 29287688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Odanacatib, A Cathepsin K-Specific Inhibitor, Inhibits Inflammation and Bone Loss Caused by Periodontal Diseases.
    Hao L; Chen J; Zhu Z; Reddy MS; Mountz JD; Chen W; Li YP
    J Periodontol; 2015 Aug; 86(8):972-83. PubMed ID: 25879791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of Innate Lymphoid Cells in Periodontal Tissue Homeostasis: A Narrative Review.
    Ma Z; Wang J; Hu L; Wang S
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms for bone resorption induced by periodontal pathogens].
    Yoshimura K; Miyamoto Y; Kamijo R
    Clin Calcium; 2012 Nov; 22(11):1685-92. PubMed ID: 23103812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of polyphenols in periodontal inflammation.
    Palaska I; Papathanasiou E; Theoharides TC
    Eur J Pharmacol; 2013 Nov; 720(1-3):77-83. PubMed ID: 24184667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage-inducible transcript 3 deficiency promotes bone resorption in murine periodontitis models.
    Luo Y; Yang B; Dong W; Yu W; Jia M; Wang J
    J Periodontal Res; 2023 Aug; 58(4):841-851. PubMed ID: 37243354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of Immune Cells and Mechanisms of Immune Responses in Periodontitis.
    Xu XW; Liu X; Shi C; Sun HC
    Chin J Dent Res; 2021 Dec; 24(4):219-230. PubMed ID: 35029093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intersection between macrophages and periodontal pathogens in periodontitis.
    Wang W; Zheng C; Yang J; Li B
    J Leukoc Biol; 2021 Sep; 110(3):577-583. PubMed ID: 34028883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Therapies for the Management of Inflammatory Bone Resorption in Periodontal Disease: A Review of Preclinical Studies.
    Pavanelli ALR; de Menezes BS; Pereira EBB; de Souza Morais FA; Cirelli JA; de Molon RS
    Biomed Res Int; 2022; 2022():5832009. PubMed ID: 35547360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the reduction of inflammatory risk associated with cardiovascular disease by treating periodontitis either alone or in combination with a systemic anti-inflammatory agent: protocol for a pilot, parallel group, randomised controlled trial.
    King S; Church L; Garde S; Chow CK; Akhter R; Eberhard J
    BMJ Open; 2022 Nov; 12(11):e063148. PubMed ID: 36410825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host modulation therapy with anti-inflammatory agents.
    Preshaw PM
    Periodontol 2000; 2018 Feb; 76(1):131-149. PubMed ID: 29193331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.
    Hamilton JA; Hasturk H; Kantarci A; Serhan CN; Van Dyke T
    Curr Atheroscler Rep; 2017 Nov; 19(12):57. PubMed ID: 29110146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central Regulatory Role of Cytokines in Periodontitis and Targeting Options.
    Plemmenos G; Evangeliou E; Polizogopoulos N; Chalazias A; Deligianni M; Piperi C
    Curr Med Chem; 2021; 28(15):3032-3058. PubMed ID: 32838709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.